본 연구에서는 참당귀(Angelica gigas Nakai)의 핵심 유효 성분인 decursin과 decursinol angelate를 높은 수율로 추출한 초임계 이산화탄소 선택 추출물의 항염증 효능을 에탄올 추출물과 비교하여 측정하였다. 항염증 효능을 측정하기 위해 염증 매개 인자인 nitric oxide(NO), 염증성 사이토카인인 interleukin(IL)-6, IL-8 생성량을 측정하였다. NO 생성량은 lipopolysaccharide(LPS)로 염증 반응을 유도한 Raw 264.7 세포를 대상으로 Griess assay를 통해 측정하였고, IL-6 및 IL-8 생성량은 tumor necrosis factor(TNF)-α로 염증 반응을 유도한 human keratinocyte cell line(HaCaT) 세포를 대상으로 enzyme-linked immunoadsorbent assay(ELISA)를 통해 측정하였다. NO 생성량은 초임계 이산화탄소 추출물이 에탄올 추출물에 비해 뛰어나게 억제하였다. IL-6 및 IL-8 생성량 또한 에탄올 추출물은 오히려 증가시키는 반면, 초임계 이산화탄소 추출물은 6.25 ㎍/mL의 농도에서 통계적으로 유의하게 억제하였다(P<0.01). 우리는 이러한 결과를 통해 참당귀 초임계 이산화탄소 선택 추출물이 아토피 피부염을 완화시키는 항염증 코스메슈티컬 소재로써 활용 가능함을 확인하였다.
본 연구에서는 참당귀(Angelica gigas Nakai)의 핵심 유효 성분인 decursin과 decursinol angelate를 높은 수율로 추출한 초임계 이산화탄소 선택 추출물의 항염증 효능을 에탄올 추출물과 비교하여 측정하였다. 항염증 효능을 측정하기 위해 염증 매개 인자인 nitric oxide(NO), 염증성 사이토카인인 interleukin(IL)-6, IL-8 생성량을 측정하였다. NO 생성량은 lipopolysaccharide(LPS)로 염증 반응을 유도한 Raw 264.7 세포를 대상으로 Griess assay를 통해 측정하였고, IL-6 및 IL-8 생성량은 tumor necrosis factor(TNF)-α로 염증 반응을 유도한 human keratinocyte cell line(HaCaT) 세포를 대상으로 enzyme-linked immunoadsorbent assay(ELISA)를 통해 측정하였다. NO 생성량은 초임계 이산화탄소 추출물이 에탄올 추출물에 비해 뛰어나게 억제하였다. IL-6 및 IL-8 생성량 또한 에탄올 추출물은 오히려 증가시키는 반면, 초임계 이산화탄소 추출물은 6.25 ㎍/mL의 농도에서 통계적으로 유의하게 억제하였다(P<0.01). 우리는 이러한 결과를 통해 참당귀 초임계 이산화탄소 선택 추출물이 아토피 피부염을 완화시키는 항염증 코스메슈티컬 소재로써 활용 가능함을 확인하였다.
In this study, the anti-inflammatory effect of supercritical carbon dioxide selective extracts, which extract decursin and decursinol angelate, the vital active ingredients of Angelica gigas Nakai, in high yield, was measured compared to that of ethanol extracts. To measure the anti-inflammatory eff...
In this study, the anti-inflammatory effect of supercritical carbon dioxide selective extracts, which extract decursin and decursinol angelate, the vital active ingredients of Angelica gigas Nakai, in high yield, was measured compared to that of ethanol extracts. To measure the anti-inflammatory effect, the production of nitric oxide(NO), an inflammatory mediator, and interleukin(IL)-6 and IL-8, inflammatory cytokines, was measured. NO production was measured by Griess assay on Raw 264.7 cells induced inflammatory response by lipopolysaccharide(LPS), and IL-6 and IL-8 production was measured by enzyme-linked immunoadsorbent assay(ELISA) on human keratinocyte cell line(HaCaT) cells induced inflammatory response by tumor necrosis factor(TNF)-α. The amount of NO production was suppressed outstandingly by the supercritical carbon dioxide extracts compared to the ethanol extracts. The amount of IL-6 and IL-8 production was increased by the ethanol extracts, whereas statistically significantly inhibited by supercritical carbon dioxide extracts at the concentration of 6.25 ㎍/mL(P<0.01). Through these results, we confirmed that the supercritical carbon dioxide selective extracts of Angelica gigas Nakai could be used as an anti-inflammatory cosmeceutical material to alleviate atopic dermatitis.
In this study, the anti-inflammatory effect of supercritical carbon dioxide selective extracts, which extract decursin and decursinol angelate, the vital active ingredients of Angelica gigas Nakai, in high yield, was measured compared to that of ethanol extracts. To measure the anti-inflammatory effect, the production of nitric oxide(NO), an inflammatory mediator, and interleukin(IL)-6 and IL-8, inflammatory cytokines, was measured. NO production was measured by Griess assay on Raw 264.7 cells induced inflammatory response by lipopolysaccharide(LPS), and IL-6 and IL-8 production was measured by enzyme-linked immunoadsorbent assay(ELISA) on human keratinocyte cell line(HaCaT) cells induced inflammatory response by tumor necrosis factor(TNF)-α. The amount of NO production was suppressed outstandingly by the supercritical carbon dioxide extracts compared to the ethanol extracts. The amount of IL-6 and IL-8 production was increased by the ethanol extracts, whereas statistically significantly inhibited by supercritical carbon dioxide extracts at the concentration of 6.25 ㎍/mL(P<0.01). Through these results, we confirmed that the supercritical carbon dioxide selective extracts of Angelica gigas Nakai could be used as an anti-inflammatory cosmeceutical material to alleviate atopic dermatitis.
S.P. Yoon, B.S. kim, J.H. Ree, S.C. Lee, and Y.K. Kim, "The environment and lifestyles of atopic dermatitis patients," Korean Journal of Dermatology, Vol. 37, No. 8, pp. 983-991, 1999.
S.K. Park and B.J Lee, "Market trends for atopy treatment cosmetics," Korean Industrial Chemistry News, Vol. 22, No. 1, pp. 3-11, 2019.
K.H. Kim, "Overview of atopic dermatitis," Asia Pacific Allergy, Vol. 3, No. 2, pp. 79-87, 2013.
J.M. Spergel and A.S. Paller, "Atopic dermatitis and the atopic march," J ournal of Allergy and Clinical Immunology, Vol. 112, No. 6, pp. S118-S127, 2003.
D.Y. Leung, M. Boguniewicz, M.D. Howell, I. Nomura, and Q.A. Hamid, "New insights into atopic dermatitis," The Journal of clinical investigation, Vol. 113, No. 5, pp. 651-657, 2004.
J.S. Kang, "Pharmacological effect of decursin, decursinol angelate, and decursinol derived fromAngelica gigas Nakai," Journal of Life Science, Vol. 31, No. 12, pp. 1128-1141, 2021.
J.S. Heo, J.Y. Cha, H.W. Kim, H.Y. Ahn, K.E. Eom, S.J. Heo, and Y.S. Cho, "Bioactive materials and biological activity in the extracts of leaf, stem mixture and root from Angelica gigas Nakai," Journal of Life science, Vol. 20, No. 5, pp. 750-759, 2010.
N.S. Seong, K.S. Kim, S.T. Lee, and S.W. Lee, "Environmental variation of decursin content in Angelica gigas," Korean Journal of Crop Science, Vol. 38, No. 1, pp. 60-65, 1993.
K.M. Kim, J.Y. Jung, S.W. Hwang, M.J. Kim, and J.S. Kang, "Isolation and purification of decursin and decursinol angelate in Angelica gigas Nakai," J ournal of the Korean Society of Food Science and Nutrition, Vol. 38, No. 5, pp. 653-656, 2009.
Y.H. Choi, E.J. Park, Y.L. Kim, Y.W. Chin, S.H. Jeon, S.N. Joung, ... and J.W. Kim, "Selective extraction of cytotoxic substances frommedicinal plants using supercritical carbon dioxide," Korean J ournal of Pharmacognosy, Vol 30, No. 1, pp. 59-64, 1999.
C.G. Pereira and M.A.A. Meireles, "Supercritical fluid extraction of bioactive compounds: funda mentals, applications and economic perspectives," Food and Bioprocess Technology, Vol. 3, No. 3, pp. 340-372, 2010.
E. Reverchon, "Supercritical fluid extraction and fractionation of essential oils and related products," The Journal of Supercritical Fluids, Vol. 10, No. 1, pp. 1-37, 1997.
S.I. Park, S.H. Heo, J. Lee, and M.S. Shin, "Extraction of active compounds from Angelica gigas using supercritical carbon dioxide and its physiological activity," Journal of Convergence for Information Technology, Vol. 11, No. 6, pp. 206-212, 2021.
S.I. Park, S.H. Heo, K.W. Lee, J.L. Kim, and M.S. Shin, "Antimicrobial effects of supercritical Angelica gigas extracts and enhancement of skin permeability using cell penetrating peptide," Turkish Journal of Computer and Mathematics Education, Vol. 12, No. 13, pp. 6063-6071, 2021.
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.